Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fmed.2021.653630 http://scihub22266oqcxt.onion/10.3389/fmed.2021.653630 34222275!8248812!34222275     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Med+(Lausanne) 2021 ; 8 (ä): 653630 Nephropedia Template TP {{tp|p=34222275|t=2021. Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population |pdf=|usr=}}{{34222275}} gab.com Text Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population JO: Front Med (Lausanne) http://www.kidney.de/pget.php?&tw=1&pmid=34222275 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic recently. The prevalence and persistence of antibodies following a peak SARS-CoV-2 infection provides insights into the potential for some level of population immunity. In June 2020, we succeeded in testing almost half of the population of an Austrian town with a higher incidence of COVID-19 infection. We performed a follow-up study to reassess the prevalence of SARS-CoV-2-specific IgA and IgG antibodies with 68 participants of the previous study. We found that the prevalence of IgG or IgA antibodies remained remarkably stable, with 84% of our cohort prevailing SARS-CoV-2-specific antibodies (only a slight decrease from 93% 4 months before). In most patients with confirmed COVID-19 seroconversion potentially provides immunity to reinfection. Our results suggest a stable antibody response observed for at least 6 months post-infection with implications for developing strategies for testing and protecting the population. Twit Text FOAVip Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population ????Front Med (Lausanne) http://www.kidney.de/pget.php?&tw=1&pmid=34222275 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34222275 #FOAvip English Wikipedia <ref>{{Cite pmid|34222275}}</ref> Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population #MMPMID34222275 Ladage D; Rosgen D; Schreiner C; Ladage D; Adler C; Harzer O; Braun RJ Front Med (Lausanne) 2021[]; 8 (ä): 653630 PMID34222275show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic recently. The prevalence and persistence of antibodies following a peak SARS-CoV-2 infection provides insights into the potential for some level of population immunity. In June 2020, we succeeded in testing almost half of the population of an Austrian town with a higher incidence of COVID-19 infection. We performed a follow-up study to reassess the prevalence of SARS-CoV-2-specific IgA and IgG antibodies with 68 participants of the previous study. We found that the prevalence of IgG or IgA antibodies remained remarkably stable, with 84% of our cohort prevailing SARS-CoV-2-specific antibodies (only a slight decrease from 93% 4 months before). In most patients with confirmed COVID-19 seroconversion potentially provides immunity to reinfection. Our results suggest a stable antibody response observed for at least 6 months post-infection with implications for developing strategies for testing and protecting the population. äPersisting Antibody Response to SARS-CoV-2 in a Local Austrian Populat(epmc).pdf DeepDyve Pubget Overpricing